» Articles » PMID: 37210503

Association of Chorioamnionitis with Infertility Treatment and Subsequent Neonatal Outcomes in the US: a Population-based Cohort Study

Overview
Publisher Biomed Central
Date 2023 May 20
PMID 37210503
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chorioamnionitis (CAM) is a common risk factor for preterm births, resulting in several adverse outcomes. The association between infertility treatment and CAM is unclear. Therefore, this study examined the association between infertility treatment and CAM and described subsequent neonatal outcomes.

Methods: This population-based cohort study used data from the National Vital Statistics System Database. We included women who had a singleton live birth from January 1, 2016 to December 31, 2018. Women-infant pairs were stratified by infertility treatment, and the main outcome was a reported diagnosis of CAM in a checkbox format: clinical CAM or maternal temperature of > 38 °C. Multivariate logistic regression was used to examine the association between infertility treatment and CAM and the effect of infertility treatment on neonatal outcomes in women diagnosed with CAM.

Results: The final sample comprised 10,900,495 woman-infant pairs, and 1.4% received infertility treatment. Compared with the natural conception group, women receiving infertility treatment had a significantly higher risk of CAM (adjusted odds ratio [aOR] 1.772 [95% confidence interval {CI}, 1.718-1.827]). Furthermore, newborns exposed to CAM had a higher risk of very low birth weight (VLBW) (aOR, 2.083 [95% CI, 1.664-2.606], P < .001), preterm birth (aOR, 1.497 [95% CI, 1.324-1.693]; P < .001), neonatal intensive care unit admission (aOR, 1.234 [95% CI, 1.156-1.317]; P < .001), and other adverse neonatal outcomes in the infertility treatment group compared with ones conceived naturally.

Conclusions: This study found that women who received infertility treatment had a higher risk of CAM. And CAM deteriorated neonatal outcomes in the infertility treatment group.

References
1.
Qin J, Sheng X, Wu D, Gao S, You Y, Yang T . Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis. Arch Gynecol Obstet. 2016; 295(2):285-301. DOI: 10.1007/s00404-016-4250-3. View

2.
Evers J . Female subfertility. Lancet. 2002; 360(9327):151-9. DOI: 10.1016/S0140-6736(02)09417-5. View

3.
Raunig J, Yamauchi Y, Ward M, Collier A . Assisted reproduction technologies alter steroid delivery to the mouse fetus during pregnancy. J Steroid Biochem Mol Biol. 2011; 126(1-2):26-34. PMC: 3114261. DOI: 10.1016/j.jsbmb.2010.12.012. View

4.
Vannuccini S, Clifton V, Fraser I, Taylor H, Critchley H, Giudice L . Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2015; 22(1):104-15. PMC: 7289323. DOI: 10.1093/humupd/dmv044. View

5.
Berntsen S, Soderstrom-Anttila V, Wennerholm U, Laivuori H, Loft A, Oldereid N . The health of children conceived by ART: 'the chicken or the egg?'. Hum Reprod Update. 2019; 25(2):137-158. DOI: 10.1093/humupd/dmz001. View